[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

2016-2020 Emerging Cancer Diagnostic Tests and Strategic Assessments of Leading Suppliers

March 2016 | 286 pages | ID: 295919B970FEN
Venture Planning Group

US$ 2,800.00 US$ 3,500.00 -20 %

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This 286-page report presents comprehensive marketing and technological assessment, as well as medical rationale and diagnostic prospects, for the major categories of both circulating and cellular tests, such as Biochemical Markers, Oncogenes, Growth Factors, Hormones, Colony Stimulating Factors, Lymphokines, Immunohistochemical Stains and others. The report includes an overview of the clinical significance and market needs for both current and emerging cancer diagnostic tests, as well as extensive listings of companies, universities and research centers developing or marketing new technologies, products, and applications. The report also presents strategic assessments of current and emerging suppliers of cancer diagnostic products, including their sales, product portfolios, distribution tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.

Contains 286 pages and 28 tables
Major Current And Emerging Cancer Diagnostic Tests
1. INTRODUCTION
2. Tumor Marker Classification
3. ACTH
4. AlphaFetoprotein (AFP)
5. Beta2 Microglobulin
6. CA 153/27.29
7. CA 19-
8. CA-
9. Calcitonin
10. Carcinoembrionic Antigen (CEA)
11. Estrogen and Progesterone Receptors
12. Ferritin
13. Gastrin
14. Human Chorionic Gonadotropin (HCG)
15. Insulin
16. NSE
17. Occult Blood
18. PAP Smear/HPV
19. Prostatic Acid Phosphatase (PAP)
20. PROSTATESPECIFIC ANTIGEN (PSA)
21. Squamous Cell Carcinoma Antigen (SCC)
22. T and B Lymphocytes
23. TdT
24. Thyroglobulin
25. Tissue Polypeptide Antigen (TPA)
26. Biochemical Tumor Markers
ADA
BProtein
PNP
5'Nucleotidase
27. Oncogenes
Abl/ablbcr
AIB1
BCL
BRCA1
CD44
Cfos
Cmyb
Cmyc
CYP
ErbB
HPC1
Nmyc
P40
P51
P53
PIK3CA
PTI
Ras
Reg
Sis
Src
28. Polypeptide Growth Factors
Basic Fibroblast Growth Factor
BetaTGF
Cachectin (TNT)
Calmodulin
ECFR
Nerve Growth Factor (NGF)
Epidermal Growth Factor (EGF)
Ornithine Decarboxylase
Transferrin
Transforming Growth FactorAlpha
29. Ectopic Hormones
30. COLONY STIMULATING FACTORS
31. Lymphokines
AlphaInterferon
B Cell Growth Factors
B Cell Growth Factor (BCGF)
GammaInterferon
Interleukin1 (IL1)
Macrophage Activating Factor
32. Immunohistochemical Stains
33. Emerging Tumor Markers
NAcetylglucosamine
Actin
AlphaActin
Antineuronal Antibodies
7B2
B 72.3
Bax
BCDF9 BLCA-
Blood Group Antigens A,B,H
CA CA 724/TAG- CA CA- CA- CAM CAR-
CathepsinD
Chromogranin A and B
Cluster 1 Antigen
Cluster5/5A Antigen
CTA CU18 DR- DUPAN-
Endometrial Bleeding Associated Factor
Endostatin
Epithelial Membrane Antigen
Feulgen Hydrolysis
Fibronectin
FSH
(1>3)Lfucosyltransferase
GastrinReleasing Peptide (GRP)
GDCFP-
Glucagon
Glycoamines
H23
Her-
Human Carcinoma Antigen
HPA HSP27
Intermediate Filaments
Cytokeratins/CK18/Cyfra 21-
Desmin
Gliofibrillary Acid Protein
Neurofilaments
Vimentin
KA
Kinases
KP16D3 LAI
Leukocyte Common Antigen
Lewis Antigens
Lysophosphatidic Acid (LPA)
Ma 695/Ma
MABDF3 MAG ME1
Minactivin
MN/CA9 MSA
Mucin Cancer Antigen (MCA)
Multiple Tumor Suppressor
Myosin
NEA- NMP22 OA-
Opiod Peptides
Pglycoprotein
Pancreatic Oncofetal Antigen (POA)
Placental Lactogen
PR92
Proliferative Index, Ki-
Px
RB Inactivation/Deletion
Ret
SCCL
Selectin
Sialic Acid
Sialyl SSEA1/SLX
SN10
Somatostatin
TA- TABA
Tachykinin
TAG TPS
Troponin
Tubulin
VCAM VEGF
Villen
COMPETITIVE PROFILES
Abbott
AdnaGen
Applied Gene Technologies
Arca Biopharma
Beckman Coulter/Danaher
Becton Dickinson
Biomedical Diagnostics
bioMerieux
BioRad
Cepheid
Correlogic Systems
Decode Genetics
Diadexus
Diagnocure
Diasorin
Eiken Chemical
Elitech Group
Enterix
Enzo Biochem
Epigenomics
Exact Sciences
Fujirebio
Hologic/GenProbe
Guided Therapeutics
Ipsogen
Kreatech/Leica
Kyowa Medex
Mackay Life Sciences
Myriad Genetics
OncoLab
OrthoClinical Diagnostics
Panacea Pharmaceuticals
Polartechnics
Polymedco
PreMD
Qiagen
Radient Pharmaceuticals
Roche
Scienion
Sequenom
Siemens Healthcare
Takara Bio
Targeted Diagnostics & Therapeutics
Thermo Fisher
Tosoh
Veridex
Wako Pure Chemicals
Wallac/PE
Zila
Appendixes
Appendix I: Major Universities and Research Centers Developing Cancer Diagnostic Technology and Applications

LIST OF TABLES

Tumor Marker Classification
Major Companies Developing or Marketing ACTH Tests
Major Companies Developing or Marketing AFP Tests
Major Companies Developing or Marketing Beta2 Microglobulin Tests
Major Companies Developing or Marketing CA 153/27.29 Tests
Major Companies Developing or Marketing CA 199 Tests
Major Companies Developing or Marketing CA 125 Tests
Major Companies Developing or Marketing Calcitonin Tests
Major Companies Developing or Marketing CEA Tests
Major Companies Developing or Marketing Estrogen Receptor Tests
Major Companies Developing or Marketing Progesterone Receptor Tests
Major Companies Developing or Marketing Ferritin Tests
Major Companies Developing or Marketing Gastrin Tests
Major Companies Developing or Marketing HCG Tests
Major Companies Developing or Marketing Insulin Tests
Major Companies Developing or Marketing NSE Tests
Major Companies Developing or Marketing Occult Blood Tests
Major Companies Developing or Marketing PAP Smear/HPV Tests
Major Companies Developing or Marketing PAP Tests
Major Companies Developing or Marketing PSA Tests
Major Companies Developing or Marketing Lymphocyte Subclassification Tests
Biochemical Markers Potential Applications In Cancer Diagnosis
Oncogenes Potential Applications In Cancer Diagnosis
Major Companies Developing or Marketing Oncogene Tests
Growth Factors Potential Applications In Cancer Diagnosis
Colony Stimulating Factors Potential Applications in Cancer Diagnosis
Lymphokines Potential Applications In Cancer Diagnosis
Immunohistochemical Stains Potential Applications in Cancer Diagnosis


More Publications